Skip to main content
Premium Trial:

Request an Annual Quote

Deep Longevity Closes Series A, Partners With Human Longevity

NEW YORK — Startup Deep Longevity said on Tuesday that it has closed a Series A round of financing and formed a partnership with genome sequencing company Human Longevity.

Spun out of Insilico Medicine in January, Deep Longevity is developing artificial intelligence-based systems to track aging based on a variety of molecular, cellular, and other biomarkers and datapoints. Its offerings include so-called aging clocks designed to provide measures of biological age.

Deep Longevity raised "a few million" dollars through the Series A, according to a spokesperson for the Hong Kong-based company who declined to provide an exact figure. The round was led by ETP Ventures and Human Longevity and Performance Impact Venture Fund, and included Bold Capital Partners, Longevity Vision Fund, Formic Ventures, and LongeVC.

Under the terms of their collaboration, Deep Longevity will make its technologies available through Human Longevity, which is using next-generation sequencing and machine learning to build a genomic and phenotypic database for personalized medicine.

Additional terms were not disclosed.

Earlier this year, San Diego-based Human Longevity sold its oncology division to NeoGenomics for $37 million in cash.

The Scan

Cell Signaling Pathway Identified as Metastasis Suppressor

A new study in Nature homes in on the STING pathway as a suppressor of metastasis in a mouse model of lung cancer.

Using Bees to Gain Insights into Urban Microbiomes

As bees buzz around, they pick up debris that provides insight into the metagenome of their surroundings, researchers report in Environmental Microbiome.

Age, Genetic Risk Tied to Blood Lipid Changes in New Study

A study appearing in JAMA Network Open suggests strategies to address high lipid levels should focus on individuals with high genetic risk and at specific ages.

Study Examines Insights Gained by Adjunct Trio RNA Sequencing in Complex Pediatric Disease Cases

Researchers in AJHG explore the diagnostic utility of adding parent-child RNA-seq to genome sequencing in dozens of families with complex, undiagnosed genetic disease.